Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FLAIR-i colchicine trial in overweight and obesity
NL-OMON54468Completed
- Sponsor
- Radboud University
- Start
- Aug 2022
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Trial of colchicine in obesity and Overweight (2 arms), sponsored by Radboud University. Primary endpoints: Brain activity related to effort and reward valuation and Behavioural weightings of effort and reward valuation. Started Aug 2022; status: completed.
02
Drugs
colchicine
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NL-OMON54468.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON54468.